FdaApplication
ANDA 201944
Identifiers
- fda_app_no: ANDA201944
Properties
| Property | Value |
|---|---|
| applicant_name | TRIS PHARMA INC |
| application_type | ANDA |
| approval_date | 2016-03-04 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 8MEQ | CAPSULE, EXTENDED RELEASE;ORAL |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 10MEQ | CAPSULE, EXTENDED RELEASE;ORAL |
2 products